ImpriMed is exhibiting at the VCS–VSSO Collaborative Conference to showcase our AI-driven Personalized Prediction Profile (PPP) for canine lymphoma. In addition, our Director of Bioscience, Dr. Ilona Holcomb, will deliver an oral abstract presentation titled, “A Multi-Omic Approach to Biomarker Discovery for the Differential Diagnosis of Feline IBD and EATL Using Minimally Invasive Specimens” on March 19. We look forward to connecting with veterinary oncologists and surgeons to discuss advances in precision diagnostics and treatment planning.
Click here to go to the official event page →ImpriMed is exhibiting at the VCS–VSSO Collaborative Conference to showcase our AI-driven Personalized Prediction Profile (PPP) for canine lymphoma. In addition, our Director of Bioscience, Dr. Ilona Holcomb, will deliver an oral abstract presentation titled, “A Multi-Omic Approach to Biomarker Discovery for the Differential Diagnosis of Feline IBD and EATL Using Minimally Invasive Specimens” on March 19. We look forward to connecting with veterinary oncologists and surgeons to discuss advances in precision diagnostics and treatment planning.
